Cargando…
Assessment of the diagnostic value of using serum CA125 and GI-RADS system in the evaluation of adnexal masses
Cancer antigen 125 (CA125) is a valuable tumor marker for ovarian cancer. Gynecology Imaging Reporting and Data System (GI-RADS) is proved to be effective at identifying the adnexal masses. We investigated whether the combination of these two methods can improve the diagnostic accuracy of ovarian ca...
Autores principales: | Zheng, Heng, Tie, Yan, Wang, Xi, Yang, Yang, Wei, Xiawei, Zhao, Xia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408110/ https://www.ncbi.nlm.nih.gov/pubmed/30762809 http://dx.doi.org/10.1097/MD.0000000000014577 |
Ejemplares similares
-
Diagnostic value of the gynecology imaging reporting and data system (GI-RADS) with the ovarian malignancy marker CA-125 in preoperative adnexal tumor assessment
por: Migda, Michal, et al.
Publicado: (2018) -
The diagnostic performance of the Gynecologic Imaging Reporting and Data System (GI-RADS) in adnexal masses
por: Guo, Wen, et al.
Publicado: (2021) -
Assessment of Diagnostic Value of Serum Ca-125 and Risk of Malignancy Index Scoring in the Evaluation of Adnexal Masses
por: Khoiwal, Kavita, et al.
Publicado: (2019) -
Efficacy of IOTA simple rules, O-RADS, and CA125 to distinguish benign and malignant adnexal masses
por: Xie, Wen ting, et al.
Publicado: (2022) -
Validation of the diagnostic efficacy of O-RADS in adnexal masses
por: Su, Na, et al.
Publicado: (2023)